Michelle Celarier
Latest Articles
Slowing Asian growth has global marts reeling
The Asian contagion swept across the globe Monday as Chinese markets closed early on cratering results. Markets worldwide shuddered on the first trading day of 2016, as the once-vaunted Chinese...
Next year's stock market will be rerun of blah 2015: analysts
Get ready for another glum year in the stock market. Next year will be “déjà vu all over again,” said David Kostin, the chief US equity strategist at Goldman Sachs,...
Hedge fund managers have reason to celebrate this holiday season
Yes, hedge fund managers, there really is a Santa Claus. Even though their performance has been bad this year, there’s no coal in their stockings. Indeed, pension fund investors might...
Small biotech hedge fund has a standout year
Betting on the next blockbuster drug has helped turn a small biotech hedge fund into one of this year’s biggest winners. The $1.4 billion Perceptive Life Sciences fund, founded in...
Decision to bet on sliding oil prices pays off for bold hedge funds
There will be blood, but also glory, in the oil patch. This year’s collapse in oil prices is providing a killing for a few bold hedge funds that defied conventional...
SEC has a new plan to go after ex-hedge fund boss Steve Cohen
The Securities and Exchange Commission just can’t let go of Michael Steinberg. The regulator said in court papers on Monday that it will try to use the former SAC Capital...
Congress puts kibosh on Fannie share sales
Sen. Bob Corker won a victory in his battle over the future of mortgage giants Fannie Mae and Freddie Mac in the $1.15 billion omnibus spending bill passed by Congress...
Larry Robbins feathers his nest with new investments
Hedge fund heavyweight Larry Robbins is one of the industry’s biggest losers this year — but that hasn’t deterred investors from pouring more than $1 billion into his new fund....
Ackman says this year will be worst ever for his hedge fund
Hedge fund mogul Bill Ackman is having his worst year ever. Ackman told investors in his publicly traded Pershing Square Holdings that the fund is down 20.8 percent through November....
DuPont-Dow merger pays off for steady hedgies
Persistence has paid off for Nelson Peltz. The billionaire investor and fellow activist Dan Loeb struggled for about two years to force change at chemical giants DuPont and Dow Chemical...
Juicy behind-the-scenes ‘Big Short’ stories
The lore of former Deutsche Bank trader Greg Lippmann’s “I’m short your house” T-shirt might be the most galling reminder of how a few contrarian Wall Streeters saw through the...
Valeant CEO won't testify at Senate drug pricing hearing
Valeant Chief Executive Michael Pearson will not testify at next week’s Senate subcommittee hearing on drug pricing. Last month, Sens. Susan Collins (R-Maine) and Claire McCaskill (D-Mo.), who together lead...
Famed short-seller Chanos can't cash in on Valeant
Legendary short-seller Jim Chanos has failed to cash in substantially on the recent crash of one of his more notable calls — Canadian drugmaker Valeant Pharmaceuticals, The Post has learned....
Key insider-trading informant stunned by 21-day jail sentence
A key informant in Manhattan US Attorney Preet Bharara’s far-ranging insider trading probe was sentenced to just 21 days in jail — but he believes even that is too much...
Ackman's hedge fund continues to struggle
It’s looking to be another bad year for hedge funds — and November just added to the pain. Hedge fund mogul Bill Ackman’s Pershing Square flagship hedge fund fell 2...
Einhorn's Greenlight Capital takes a beating on energy bets
Hedge fund investor David Einhorn’s energy bets are still hurting his investors. Einhorn’s Greenlight Capital Re, which invests alongside his hedge fund, fell 3.9 percent in November, the company reported...
Feds seek to drop ex-hedgie's lawsuit against Bharara, FBI
The fallout from Manhattan US Attorney Preet Bharara’s massive insider trading crackdown isn’t over. The feds asked a Manhattan federal judge on Friday to throw out a lawsuit leveled against...
Investors bid up Valeant stock nearly 16 percent
Maybe Valeant’s $30 billion debt load won’t crush it after all. That seems to be the view of investors who bid up the battered stock nearly 16 percent on Thursday,...
Ackman's hedge fund slammed by Valeant woes
Bill Ackman’s annus horribilis continued this week, with his publicly traded Pershing Square Holdings hedge fund down 24.5 percent for the year through Tuesday. His $15 billion firm has been...
Slow-selling 'female Viagra' is giving Valeant a headache
Maybe women just don’t have as many problems in the sack as men. Addyi, the new female libido pill, was all but ignored in its first few weeks on the...